Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

The economic burden of posttransplant events in renal transplant recipients in Europe.

Chamberlain G, Baboolal K, Bennett H, Pockett RD, McEwan P, Sabater J, Sennfält K.

Transplantation. 2014 Apr 27;97(8):854-61. doi: 10.1097/01.TP.0000438205.04348.69.

PMID:
24732898
2.

The Economic Burden of Posttransplant Events in Renal Transplant Recipients in Europe.

Chamberlain G, Baboolal K, Bennett H, Pockett RD, McEwan P, Sabater J, Sennfält K.

Transplantation. 2014 Jan 22. [Epub ahead of print]

PMID:
24458103
3.

Economic burden of bilateral neovascular age-related macular degeneration: multi-country observational study.

Cruess AF, Zlateva G, Xu X, Soubrane G, Pauleikhoff D, Lotery A, Mones J, Buggage R, Schaefer C, Knight T, Goss TF.

Pharmacoeconomics. 2008;26(1):57-73.

PMID:
18088159
4.

Organ quality metrics are a poor predictor of costs and resource utilization in deceased donor kidney transplantation.

Stahl CC, Wima K, Hanseman DJ, Hoehn RS, Ertel A, Midura EF, Hohmann SF, Paquette IM, Shah SA, Abbott DE.

Surgery. 2015 Dec;158(6):1635-41. doi: 10.1016/j.surg.2015.05.014. Epub 2015 Jun 19.

PMID:
26096564
5.

Resource use and treatment costs after kidney transplantation: impact of demographic factors, comorbidities, and complications.

Hagenmeyer EG, Häussler B, Hempel E, Grannas G, Kaló Z, Kilburg A, Nashan B.

Transplantation. 2004 May 27;77(10):1545-50.

PMID:
15239619
6.

The cost effectiveness of tacrolimus versus microemulsified cyclosporin: a 10-year model of renal transplantation outcomes.

Orme ME, Jurewicz WA, Kumar N, McKechnie TL.

Pharmacoeconomics. 2003;21(17):1263-76.

PMID:
14986738
7.

The cost implications of first anniversary renal function after living, standard criteria deceased and expanded criteria deceased donor kidney transplantation.

Schnitzler MA, Gheorghian A, Axelrod D, L'Italien G, Lentine KL.

J Med Econ. 2013;16(1):75-84. doi: 10.3111/13696998.2012.722571. Epub 2012 Sep 25.

PMID:
22905738
8.

The economic implications of HLA matching in cadaveric renal transplantation.

Schnitzler MA, Hollenbeak CS, Cohen DS, Woodward RS, Lowell JA, Singer GG, Tesi RJ, Howard TK, Mohanakumar T, Brennan DC.

N Engl J Med. 1999 Nov 4;341(19):1440-6.

9.

Predicting renal failure after liver transplantation from measured glomerular filtration rate: review of up to 15 years of follow-up.

Sanchez EQ, Melton LB, Chinnakotla S, Randall HB, McKenna GJ, Ruiz R, Onaca N, Levy MF, Goldstein RM, Klintmalm GB.

Transplantation. 2010 Jan 27;89(2):232-5. doi: 10.1097/TP.0b013e3181c42ff9.

PMID:
20098288
10.

The implications of acute rejection and reduced allograft function on health care expenditures in contemporary US kidney transplantation.

Gheorghian A, Schnitzler MA, Axelrod DA, Kalsekar A, L'italien G, Lentine KL.

Transplantation. 2012 Aug 15;94(3):241-9. doi: 10.1097/TP.0b013e318255f839.

PMID:
22874796
11.

Primary kidney disease and post-renal transplantation hospitalization costs.

Ghoddousi K, Ramezani MK, Assari S, Lankarani MM, Amini M, Khedmat H, Hollisaaz MT.

Transplant Proc. 2007 May;39(4):962-5.

PMID:
17524863
12.
13.

The natural history of renal function following orthotopic heart transplant.

Al Aly Z, Abbas S, Moore E, Diallo O, Hauptman PJ, Bastani B.

Clin Transplant. 2005 Oct;19(5):683-9.

PMID:
16146562
14.

Resource utilization among kidney transplant recipients.

Khan S, Tighiouart H, Kalra A, Raman G, Rohrer RJ, Pereira BJ.

Kidney Int. 2003 Aug;64(2):657-64.

15.

The UNOS Scientific Renal Transplant Registry.

Cecka JM.

Clin Transpl. 1999:1-21.

PMID:
11038622
16.

Direct costs of glaucoma and severity of the disease: a multinational long term study of resource utilisation in Europe.

Traverso CE, Walt JG, Kelly SP, Hommer AH, Bron AM, Denis P, Nordmann JP, Renard JP, Bayer A, Grehn F, Pfeiffer N, Cedrone C, Gandolfi S, Orzalesi N, Nucci C, Rossetti L, Azuara-Blanco A, Bagnis A, Hitchings R, Salmon JF, Bricola G, Buchholz PM, Kotak SV, Katz LM, Siegartel LR, Doyle JJ.

Br J Ophthalmol. 2005 Oct;89(10):1245-9.

17.

Cost of disorders of the brain in Europe 2010.

Gustavsson A, Svensson M, Jacobi F, Allgulander C, Alonso J, Beghi E, Dodel R, Ekman M, Faravelli C, Fratiglioni L, Gannon B, Jones DH, Jennum P, Jordanova A, Jönsson L, Karampampa K, Knapp M, Kobelt G, Kurth T, Lieb R, Linde M, Ljungcrantz C, Maercker A, Melin B, Moscarelli M, Musayev A, Norwood F, Preisig M, Pugliatti M, Rehm J, Salvador-Carulla L, Schlehofer B, Simon R, Steinhausen HC, Stovner LJ, Vallat JM, Van den Bergh P, van Os J, Vos P, Xu W, Wittchen HU, Jönsson B, Olesen J; CDBE2010Study Group..

Eur Neuropsychopharmacol. 2011 Oct;21(10):718-79. doi: 10.1016/j.euroneuro.2011.08.008. Epub 2011 Sep 15. Erratum in: Eur Neuropsychopharmacol. 2012 Mar;22(3):237-8. den Bergh, Peter Van [corrected to Van den Bergh, Peter].

PMID:
21924589
18.
19.

The relationship between kidney function and long-term graft survival after kidney transplant.

Kasiske BL, Israni AK, Snyder JJ, Skeans MA; Patient Outcomes in Renal Transplantation (PORT) Investigators..

Am J Kidney Dis. 2011 Mar;57(3):466-75. doi: 10.1053/j.ajkd.2010.10.054. Epub 2011 Jan 22.

PMID:
21257243
20.

Estimated one-year glomerular filtration rate is the best predictor of long-term graft function following renal transplant.

Salvadori M, Rosati A, Bock A, Chapman J, Dussol B, Fritsche L, Kliem V, Lebranchu Y, Oppenheimer F, Pohanka E, Tufveson G, Bertoni E.

Transplantation. 2006 Jan 27;81(2):202-6.

PMID:
16436963

Supplemental Content

Support Center